Clinical Trials for HER2 Negative Breast Carcinoma

Find clinical trials for her2 negative breast carcinoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

NCT ID: NCT04379570

This clinical trial is looking at how an additional support program, which includes text message reminders and phone counseling, can help breast cancer patients stick to their prescribed medication...

Recruiting

Phase: PHASE3 Type: interventional Locations: Brooklyn, New York, United States, Milwaukee, Wisconsin, United States +596 more

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT ID: NCT06678269

This clinical trial is investigating the use of a medication called abemaciclib in combination with radiation therapy for people with metastatic breast cancer, which is cancer that has spread beyon...

Recruiting

Phase: PHASE1 Type: interventional Locations: Harrison, New York, United States, Middletown, New Jersey, United States +5 more

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

NCT ID: NCT06016738

This clinical trial is studying a new treatment called palazestrant (also known as OP-1250) to see if it is safer and more effective than current standard treatments for people with advanced breast...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Dallas, Texas, United States +176 more

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

NCT ID: NCT06774027

This clinical trial is studying the use of a new type of treatment called antibody-drug conjugates (ADCs) for patients with advanced breast cancer that is either HER2-negative or hormone receptor-p...

Not yet recruiting

Type: observational Locations: San Francisco, California, United States

Neoadjuvant Breast Cancer Time Restricted Eating

NCT ID: NCT05327608

This clinical trial is studying a new approach called time-restricted eating (TRE) for patients with certain types of breast cancer who are starting chemotherapy. In this trial, participants will f...

Recruiting

Phase: NA Type: interventional Locations: Philadelphia, Pennsylvania, United States

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

NCT ID: NCT06176261

The DATO-BASE clinical trial is studying a new drug called datopotamab deruxtecan to see how safe and effective it is for treating breast cancer that has spread to the brain. This trial is specific...

Recruiting

Phase: PHASE2 Type: interventional Locations: Durham, North Carolina, United States, Boston, Massachusetts, United States +2 more

SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells

NCT ID: NCT04150042

The SHARON clinical trial is studying a new treatment approach for patients with advanced (stage IV) cancer who have specific genetic mutations called BRCA1, BRCA2, or PALB2. This treatment combine...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions